| Identification | Back Directory | [Name]
Des[N-[(1S)-1-[2-(cyclopropylaMino)-2-oxoacetyl]butyl]carboxaMido] 1-Carboxy Telaprevir | [CAS]
402958-98-9 | [Synonyms]
(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(pyrazin
Cyclopentenoncyanhydrin Glycoside Gynocardin
Des[N-[(1S)-1-[2-(cyclopropylaMino)-2-oxoacetyl]butyl]carboxaMido] 1-Carboxy Telaprevir
(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-Methyl-L-valyloctahydrocyclopenta[c]pyrrole-1-carboxylic Acid
Cyclopenta[c]pyrrole-1-carboxylic acid, (2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-Methyl-L-valyloctahydro-, (1S,3aR,6aS)-
Cyclopenta[c]pyrrole-1-carboxylic acid, (2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-Methyl-L-valyloctahydro-, (1S,3aR,6aS)-
(3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylicaci
(3S,3AS,6AR)-2-[(2S)-2-[[(2S)-2-CYCLOHEXYL-2-(PYRAZINE-2-CARBONYLAMINO)ACETYL]AMINO]-3,3-DIMETHYLBUTANOYL]-3,3A,4,5,6,6A-HEXAHYDRO-1H-CYCLOPENTA[C]PYRROLE-3-CARBOXYLIC ACID | [Molecular Formula]
C27H39N5O5 | [MDL Number]
MFCD19105536 | [MOL File]
402958-98-9.mol | [Molecular Weight]
513.63 |
| Chemical Properties | Back Directory | [Melting point ]
>120oC (dec.) | [Boiling point ]
818℃ | [density ]
1.238 | [Fp ]
448℃ | [storage temp. ]
Refrigerator | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
3.34±0.20(Predicted) | [color ]
Off-White |
| Hazard Information | Back Directory | [Uses]
An intermediate in the preparation of Telaprevir (T015650) as hepatitis C virus (HCV) protease inhibitor. | [Uses]
An intermediate in the preparation of Telaprevir (T015650) as hepatitis C virus (HCV) protease inhibitor. It is a COVID19-related research product. |
|
| Company Name: |
Eastbang Pharmaceuticals Technology Co., Ltd.
|
| Tel: |
+86 (20) 28996708,29078958,28139708,29076128,28133708,28139728,28139738,28133718,021-31663278,021-31663578,021-60538387 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList13633/0.htm |
|